IMDX
Nuveen Asset Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,027,493
| Closed | -$1.45M | – | 3350 |
|
|
2022
Q1 | $1.45M | Sell |
1,027,493
-269,023
| -21% | -$379K | ﹤0.01% | 2661 |
|
|
2021
Q4 | $2.72M | Sell |
1,296,516
-112,165
| -8% | -$235K | ﹤0.01% | 2409 |
|
|
2021
Q3 | $5.59M | Sell |
1,408,681
-53,483
| -4% | -$212K | ﹤0.01% | 2140 |
|
|
2021
Q2 | $8.39M | Buy |
1,462,164
+483,320
| +49% | +$2.77M | ﹤0.01% | 1978 |
|
|
2021
Q1 | $5.08M | Buy |
978,844
+735,909
| +303% | +$3.82M | ﹤0.01% | 2162 |
|
|
2020
Q4 | $580K | Buy |
242,935
+21,594
| +10% | +$51.6K | ﹤0.01% | 3004 |
|
|
2020
Q3 | $308K | Sell |
221,341
-59,174
| -21% | -$82.3K | ﹤0.01% | 3083 |
|
|
2020
Q2 | $536K | Buy |
280,515
+193,972
| +224% | +$371K | ﹤0.01% | 2870 |
|
|
2020
Q1 | $212K | Buy |
86,543
+27,665
| +47% | +$67.8K | ﹤0.01% | 2979 |
|
|
2019
Q4 | $132K | Sell |
58,878
-8,018
| -12% | -$18K | ﹤0.01% | 3109 |
|
|
2019
Q3 | $141K | Sell |
66,896
-31,801
| -32% | -$67K | ﹤0.01% | 3149 |
|
|
2019
Q2 | $246K | Buy |
+98,697
| New | +$246K | ﹤0.01% | 3138 |
|